Form 4: Wellgistics Health Director Rebecca Shanahan Acquires 200,000 Shares of Common Stock

Rebecca Shanahan, a director at Wellgistics Health, acquired 200,000 shares of common stock and disposed of an unspecified amount, according to a recent SEC filing.

Summary

• On March 21, 2025, Rebecca Shanahan, a director of Wellgistics Health, Inc. (WGRX), acquired 200,000 shares of common stock.
• The acquisition was made directly.
• Following the transaction, Shanahan beneficially owns 244,720 shares of Wellgistics Health common stock.
• The shares of restricted stock were issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan.
• 66,000 shares vested immediately, 67,000 shares will vest on March 4, 2026, and 67,000 shares will vest on March 4, 2027.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director. The acquisition itself can be seen as a slightly positive sign, but without more context, it's difficult to gauge the overall impact.

Positives

• A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• Shareholders may view the director's stock acquisition as a positive signal.

Key Dates

Keywords

Wellgistics Health, Rebecca Shanahan, Director, Stock Acquisition, Common Stock, Beneficial Ownership, SEC Form 4, Equity Incentive Plan, Restricted Stock, Vesting